Tradestie Institutional Equity Comparison Engine
SNYR vs CAH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAH Overall Edge
CAH Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cardinal Health, Inc. (CAH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNYR counters with relative strength in Valuation. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus CAH at 22.6x Forward P/E and 1.3% operating margin (+5.5% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CAH sits in BREAKOUT (59th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SNYR
SNYR 0.6x vs CAH 22.6x Fwd P/E
Growth & Margin Winner
CAH
Op Margin -10.3% vs 1.3% ยท YoY -32.8% vs +5.5%
Momentum & Technical Winner
CAH
1Y -96.2% vs +31.5% ยท 52W Pos 1% vs 87%
Options & Structure Winner
CAH
UNCLASSIFIED (N/A IV) vs BREAKOUT (59th %ile IV)
SNYR
NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap
$4.1M
1M Return
-16.28%
1Y Return
-96.15%
Forward P/E
0.6x
Unified AI Score
48.9 / 100
HOLD
Tech 55.0
Fund 39.0
Flow 50.0
Mom 60.0
CAH
NYSE
Cardinal Health, Inc.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$272.81
+0.17% 1D
Market Cap
$62.9B
1M Return
+6.72%
1Y Return
+31.46%
Forward P/E
22.6x
Unified AI Score
42.7 / 100
HOLD
Tech 24.0
Fund 39.0
Flow 59.0
Mom 36.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SNYR -96.15%
CAH +31.46%
Spread: +105.2 pp (CAH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SNYR Revenue | CAH Revenue | SNYR Op. Margin | CAH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $30M | $145.5B | -27.1% | 1.4% | CAH |
| FY2020 | N/A | $152.9B | N/A | -2.7% | CAH |
| FY2021 | N/A | $162.5B | N/A | 0.3% | CAH |
| FY2022 | N/A | $181.3B | N/A | -0.3% | CAH |
| FY2023 | $40M | $205.0B | 25.3% | 0.4% | SNYR |
| FY2024 | $30M | $226.8B | 16.7% | 0.5% | SNYR |
| FY2025 | $30M | $222.6B | -27.8% | 1.0% | CAH |
| FY2026 | N/A | $254.2B | N/A | 1.0% | CAH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SNYR | CAH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.1M | $62.9B | Larger Scale | CAH |
| Trailing P/E Ratio Valuation | 0.6x | 35.2x | Lower Multiple | SNYR |
| Forward P/E Ratio Valuation | 0.6x | 22.6x | Lower Multiple | SNYR |
| Revenue Growth (YoY) Growth | -32.8% | +5.5% | Higher Growth | CAH |
| Operating Margin (TTM) Profitability | -10.3% | 1.3% | Higher Margin | CAH |
| Net Profit Margin Profitability | -57.0% | 0.7% | Higher Margin | CAH |
| Return on Equity (ROE) Capital Efficiency | -361.1% | 0.0% | Higher ROE | CAH |
| 52-Week Range Position Momentum | 1% ($0โ$3) | 87% ($180โ$286) | Stronger Trend | CAH |
| Beta / 30D Volatility Risk Regime | -0.86ฮฒ ยท 868% Vol | -0.03ฮฒ ยท 24% Vol | Lower Realized Risk | CAH |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 42.7 / 100 (HOLD) | Higher Composite | SNYR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SNYR vs CAH Buy Guide
SNYR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CAH
BREAKOUT
97d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
59th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SNYR nor CAH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.